کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2083586 1545339 2014 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی بیوتکنولوژی یا زیست‌فناوری
پیش نمایش صفحه اول مقاله
Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles
چکیده انگلیسی


• Roxithromycin was incorporated into poly(epsilon-caprolactone) nanoparticles.
• Nanoparticles were applied on human skin as a suspension or lecithin organogel.
• Fluorescence was observed deep in hair follicles for both formulations.
• Preferential targeting of nanoparticles to the pilosebaceous unit was proved.

Drug delivery into hair follicles with the use of nanoparticles (NPs) is gaining more importance as drug-loaded NPs may accumulate in hair follicle openings. The aim was to develop and evaluate a pluronic lecithin organogel (PLO) with roxithromycin (ROX)-loaded NPs for follicular targeting. Polymeric NPs were evaluated in terms of particle shape, size, zeta potential, suspension stability, encapsulation efficiency and in vitro drug release. Lyophilized NPs were incorporated into the PLO and rheological measurements of the nanoparticles-embedded organogels were done. The fate of the NPs in the skin was traced by incorporation of a fluorescent dye into the NPs. As a result, ROX was efficiently incorporated into polymeric NPs characterized by the appropriate size (approximately 300 nm) allowing drug delivery to hair follicles. In ex vivo human skin penetration studies, horizontal skin sections revealed fluorescence deep in the hair follicles. Although the organogel has higher affinity to the lipidic follicular area than an aqueous suspension of NPs, it did not seem to improve penetration of the NPs along the hair shaft. The results proved that it was possible to achieve preferential targeting to the pilosebaceous unit using polymeric NPs formulated either into the aqueous suspension or semisolid topical formulation.

Figure optionsDownload high-quality image (98 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 88, Issue 1, September 2014, Pages 75–84
نویسندگان
, , , , , , , ,